<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromosomal translocations juxtaposing immunoglobulin (Ig) and MYC genes are the hallmarks of human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), with deregulated MYC expression being a critical factor in pathogenesis </plain></SENT>
<SENT sid="1" pm="."><plain>By inserting an intact mouse Myc gene into the mouse genome, proximal to the Ig enhancer Emu, the effect of a precise mimic of the major t(8;14) translocation of human endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (eBL) could be investigated </plain></SENT>
<SENT sid="2" pm="."><plain>Knock-in mice developed IgM-positive B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, with most being typical of eBL by histology and immunophenotype, including expression of the germinal center (GC)-associated protein, BCL6 </plain></SENT>
<SENT sid="3" pm="."><plain>Unlike eBL, however, analysis of Ig V(H) sequences revealed no significant level of <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, constitutive expression of Myc in the knock-in mice is apparently able to induce "Burkitt-like" <z:hpo ids='HP_0002665'>lymphomas</z:hpo> before antigen stimulation and formation of a GC </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, human eBL development occurs in a GC or post-GC site with a likely contribution to pathogenesis from Epstein-Barr virus (EBV) and other epigenetic factors </plain></SENT>
</text></document>